Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Vulvar Cancer Clinical Trials, Gynecologic Oncology GOG

Matthew Powell

MD

🏢Washington University School of Medicine / Siteman Cancer Center🌐USA

Professor, Gynecologic Oncology

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Matthew Powell is a gynecologic oncologist who leads clinical trial development through the NRG Oncology/GOG framework and has contributed to studies evaluating pembrolizumab and other checkpoint inhibitors in vulvar squamous cell carcinoma. He has participated in chemoradiation trials for locally advanced vulvar cancer using cisplatin-based sensitizing regimens and has contributed to biomarker analyses examining PD-L1 expression and HPV status as predictors of immunotherapy response in vulvar cancer. He chairs multiple NRG gynecologic oncology committees.

Share:

🧪Research Fields 研究领域

vulvar cancer pembrolizumab clinical trials
GOG gynecologic oncology group trials
vulvar cancer chemoradiation cisplatin
gynecologic oncology clinical trials design
cervical vulvar IO immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Matthew Powell 的研究动态

Follow Matthew Powell's research updates

留下邮箱,当我们发布与 Matthew Powell(Washington University School of Medicine / Siteman Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment